Results 231 to 240 of about 1,199,246 (381)
TGF-β Family Signaling in Connective Tissue and Skeletal Diseases.
E. MacFarlane +3 more
semanticscholar +1 more source
This review summarizes artificial intelligence (AI)‐supported nonpharmacological interventions for adults with chronic rheumatic diseases, detailing their components, purpose, and current evidence base. We searched Embase, PubMed, Cochrane, and Scopus databases for studies describing AI‐supported interventions for adults with chronic rheumatic diseases.
Nirali Shah +5 more
wiley +1 more source
Hearing Loss in Connective Tissue Diseases: A Systematic Review. [PDF]
Skare TL, Freire de Carvalho J.
europepmc +1 more source
Objective Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centered care and informing local service pathways and care guidelines or standards.
Sonia Ranelli +8 more
wiley +1 more source
Leveraging Lifestyle Medicine for Better Outcomes in Connective Tissue Diseases. [PDF]
Bhanusali N.
europepmc +1 more source
Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla +13 more
wiley +1 more source
Characteristics of Corticosteroid-Resistant Secondary Immune Thrombocytopenia Associated With Connective Tissue Diseases in China: A Retrospective Comparative Study. [PDF]
Chen Y +6 more
europepmc +1 more source
FRI0377 Abnormal nailfold capillaroscopy pattern is common in patients with connective tissue disease and associated with organ involvement [PDF]
AM van Roon +7 more
openalex +1 more source

